Navin Molecular, an Indian-based CDMO that is part of Navin Fluorine, has announced plans to build $35 million, 9,000 m² multi-purpose GMP plant at Dewas. This is due to be completed in Q2 225. The facility will add 200 m³ of capacity, taking the total at Dewas to 420. It will support existing commercial-scale projects, as well as meeting future demands, the company said.